Medicare Enrolled
Dr. Durga Madala, M.D.
Cardiovascular Disease · San Jose, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Madala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Madala
Dr. Durga Madala is a cardiovascular disease specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Madala performed 8,923 Medicare services across 6,149 unique beneficiaries.
Between the years covered by Open Payments, Dr. Madala received a total of $11,240 from 52 pharmaceutical and/or device companies across 569 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Madala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$11,240 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,923
Medicare services
Top 8% in CA for cardiovascular disease
6,149
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~470 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,710 | $13 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,470 | $110 | $219 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,200 | $84 | $168 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
1,077 | $191 | $560 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
902 | $1 | $10 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
416 | $44 | $100 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
352 | $197 | $458 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
255 | $36 | $250 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
246 | $229 | $573 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
227 | $144 | $345 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
224 | $6 | $61 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
167 | $73 | $135 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
129 | $62 | $204 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
126 | $461 | $999 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
90 | $7 | $150 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
80 | $22 | $200 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
79 | $12 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $107 | $204 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
57 | $26 | $60 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $152 | $378 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $23 | $42 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.1% high complexity
18.1% medium
57.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,240
Total received (2018-2024)
Avg $1,606/year across 7 years
Top 25% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
569
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,497 (93.4%)
Other
Charitable contributions, space rental, and other categories
$533 (4.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,355
2023
$1,544
2022
$702
2021
$717
2020
$1,744
2019
$1,993
2018
$2,184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$365
Kiniksa Pharmaceuticals International, plc
$283
Esperion Therapeutics, Inc.
$241
Novartis Pharmaceuticals Corporation
$230
Edwards Lifesciences Corporation
$168
Amgen Inc.
$157
Merck Sharp & Dohme LLC
$151
PFIZER INC.
$148
ABBVIE INC.
$99
Boston Scientific Corporation
$90
Lexicon Pharmaceuticals, Inc.
$82
Novo Nordisk Inc
$76
HEARTFLOW, INC.
$68
Bayer Healthcare Pharmaceuticals Inc.
$49
SANOFI-AVENTIS U.S. LLC
$35
Currax Pharmaceuticals LLC
$29
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Janssen Pharmaceuticals, Inc
$22
Cleerly, Inc.
$16
Top 3 companies account for 37.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,243
AstraZeneca Pharmaceuticals LP
$922
Novartis Pharmaceuticals Corporation
$821
Kowa Pharmaceuticals America, Inc.
$820
Janssen Pharmaceuticals, Inc
$706
PFIZER INC.
$675
Welch Allyn
$533
Merck Sharp & Dohme LLC
$395
BIOTRONIK INC.
$367
Esperion Therapeutics, Inc.
$340
ARBOR PHARMACEUTICALS, INC.
$334
Boehringer Ingelheim Pharmaceuticals, Inc.
$297
Kiniksa Pharmaceuticals International, plc
$283
Bardy Diagnostics, Inc.
$268
Regeneron Healthcare Solutions, Inc.
$256
Akcea Therapeutics, Inc.
$220
Boston Scientific Corporation
$214
Lundbeck LLC
$210
Edwards Lifesciences Corporation
$201
Alnylam Pharmaceuticals Inc.
$169
Arbor Pharmaceuticals, Inc.
$149
Amarin Pharma Inc.
$145
AbbVie, Inc.
$145
Kiniksa Pharmaceuticals, Ltd.
$136
ABIOMED
$125
Lexicon Pharmaceuticals, Inc.
$115
AtriCure, Inc.
$111
ABBVIE INC.
$99
SANOFI-AVENTIS U.S. LLC
$91
Gilead Sciences, Inc.
$78
Novo Nordisk Inc
$76
Otsuka America Pharmaceutical, Inc.
$76
HEARTFLOW, INC.
$68
Allergan Inc.
$56
Bayer Healthcare Pharmaceuticals Inc.
$49
iRhythm Technologies, Inc.
$43
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$41
AbbVie Inc.
$40
Abbott Laboratories
$40
E.R. Squibb & Sons, L.L.C.
$35
Currax Pharmaceuticals LLC
$29
Noden Pharma USA Inc
$26
Medicure Pharma Inc.
$25
Aegerion Pharmaceuticals, Inc.
$25
Relypsa, Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$23
Astellas Pharma US Inc
$22
Braemar Manufacturing, LLC
$18
Cleerly, Inc.
$16
IBSA Pharma Inc.
$14
Philips Electronics North America Corporation
$12
Medtronic Vascular, Inc.
$11
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · Arcalyst · BRILINTA · BYSTOLIC · Bidil · CAMZYOS · CONTRAVE · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Cleerly Ischemia · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · FFRct · Impella · Inpefa · JARDIANCE · JUXTAPID · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LifeVest · Livalo · MULTAQ · Mitra Clip system · MitraClip System · Models · NEXLETOL · NORTHERA · ONPATTRO · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Rivacor 7 DR-T · SAMSCA · SYNTHROID · Spot Vital Signs 4400 Device · Synthroid · TEGSEDI · TEKTURNA · Tirosint · VERQUVO · VRAYLAR · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN FLX · XARELTO · ZIO XT Patch · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
205
Per 100K population
10.8
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Madala is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Madala experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Madala performed 1,710 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madala receive payments from pharmaceutical companies?
Yes. Dr. Madala received a total of $11,240 from 52 companies across 569 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madala's costs compare to other cardiologists in San Jose?
Dr. Madala's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Jose
Browse cardiologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology